TY - JOUR
T1 - Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis
AU - Ahmed, Shanzeh
AU - Fransen, Nina
AU - Touil, Hanane
AU - michailidou, Iliana
AU - Huitinga, Inge
AU - Gommerman, Jennifer
AU - Bar-Or, Amit
AU - Ramaglia, Valeria
N1 - Funding Information:
This study was funded by the National Multiple Sclerosis Society (grant RG 4775A1/1). We thank the donors of the NBB.
Funding Information:
consultant for Roche (Canada) and held grants from Novartis, EMD Serono, and Roche. ABO has participated as a speaker in meetings sponsored by and received consulting fees from Accure Therapeutics, Atara Biotherapeutics, Biogen, Bristol Myers Squibb/Celgene/Receptos, GlaxoSmithKline, Gossamer, Janssen/ Actelion, Medimmune, Merck/EMD Serono, Novartis, Roche/Genentech, and Sanofi and has received grant support to the University of Pennsylvania from Biogen Idec, Roche/Genentech, Merck/EMD Serono, and Novartis. VR is coinventor of a patent (WO2008044928) that describes the use of inhibitors of the terminal complement pathway for therapeutic purposes; she received consulting honoraria from Merck/EMD Serono and Fluidigm.
Publisher Copyright:
© 2022, Ahmed et al.
PY - 2022/3/8
Y1 - 2022/3/8
N2 - Subpial cortical demyelination is an important component of multiple sclerosis (MS) pathology contributing to disease progression, yet mechanism(s) underlying its development remain unclear. Compartmentalized inflammation involving the meninges may drive this type of injury. Given recent findings identifying substantial white matter (WM) lesion activity in patients with progressive MS, elucidating whether and how WM lesional activity relates to meningeal inflammation and subpial cortical injury is of interest. Using postmortem FFPE tissue blocks (range, 5-72 blocks; median, 30 blocks) for each of 27 patients with progressive MS, we assessed the relationship between meningeal inflammation, the extent of subpial cortical demyelination, and the state of subcortical WM lesional activity. Meningeal accumulations of T cells and B cells, but not myeloid cells, were spatially adjacent to subpial cortical lesions, and greater immune cell accumulation was associated with larger subpial lesion areas. Patients with a higher extent of meningeal inflammation harbored a greater proportion of active and mixed active/inactive WM lesions and an overall lower proportion of inactive and remyelinated WM lesions. Our findings support the involvement of meningeal lymphocytes in subpial cortical injury and point to a potential link between inflammatory subpial cortical demyelination and pathological mechanisms occurring in the subcortical WM.
AB - Subpial cortical demyelination is an important component of multiple sclerosis (MS) pathology contributing to disease progression, yet mechanism(s) underlying its development remain unclear. Compartmentalized inflammation involving the meninges may drive this type of injury. Given recent findings identifying substantial white matter (WM) lesion activity in patients with progressive MS, elucidating whether and how WM lesional activity relates to meningeal inflammation and subpial cortical injury is of interest. Using postmortem FFPE tissue blocks (range, 5-72 blocks; median, 30 blocks) for each of 27 patients with progressive MS, we assessed the relationship between meningeal inflammation, the extent of subpial cortical demyelination, and the state of subcortical WM lesional activity. Meningeal accumulations of T cells and B cells, but not myeloid cells, were spatially adjacent to subpial cortical lesions, and greater immune cell accumulation was associated with larger subpial lesion areas. Patients with a higher extent of meningeal inflammation harbored a greater proportion of active and mixed active/inactive WM lesions and an overall lower proportion of inactive and remyelinated WM lesions. Our findings support the involvement of meningeal lymphocytes in subpial cortical injury and point to a potential link between inflammatory subpial cortical demyelination and pathological mechanisms occurring in the subcortical WM.
UR - http://www.scopus.com/inward/record.url?scp=85125914685&partnerID=8YFLogxK
U2 - 10.1172/jci.insight.151683
DO - 10.1172/jci.insight.151683
M3 - Article
C2 - 35104246
VL - 7
JO - JCI Insight
JF - JCI Insight
IS - 5
M1 - e151683
ER -